SNWV
SANUWAVE Health, Inc.
5.50$
+6.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 36.3% | 43.6% | 46.4% | 41.5% | 45.3% | 61.1% | 61.0% | 61.0% | 63.6% | 65.9% | 64.6% | 63.4% | |
| 5.4% | 8.0% | 12.6% | 11.7% | 14.9% | 34.0% | 27.6% | 25.7% | 27.0% | 32.0% | 29.1% | 25.6% | |
| 5.4% | 8.0% | 12.6% | 11.7% | 14.9% | 34.0% | 27.6% | 25.7% | 27.0% | 32.0% | 29.1% | 25.6% | |
| 15.9% | 14.8% | 12.9% | 15.0% | 13.0% | 11.1% | 12.5% | 11.6% | 13.0% | 14.5% | 16.2% | 15.8% | |
| 8.4% | 13.2% | 10.6% | 13.0% | 15.7% | 13.8% | 17.7% | 17.9% | 19.1% | 15.9% | 15.9% | 19.3% | |
| 35.7% | 32.4% | 31.1% | 34.6% | 33.2% | 24.1% | 23.5% | 22.0% | 20.4% | 19.4% | 19.6% | 19.8% | |
| 22.7% | 19.8% | 18.3% | 19.4% | 17.9% | 12.4% | 11.5% | 10.2% | 9.0% | 8.1% | 7.9% | 7.9% | |
| 424.2% | 292.6% | 304.1% | 288.5% | 375.9% | 142.2% | 156.0% | 144.7% | 108.2% | 95.7% | 95.0% | 92.4% | |
| 420.0% | 288.9% | 300.9% | 285.4% | 373.2% | 140.6% | 153.2% | 140.7% | 55.0% | 47.8% | 49.3% | 49.6% | |
| 192.6% | 140.3% | 130.7% | 155.4% | 149.2% | 84.0% | 85.2% | 81.6% | 16.3% | 15.5% | 15.9% | 15.3% | |
| 22.7% | 25.5% | 21.7% | 18.5% | 18.9% | 12.4% | 13.5% | 12.1% | 11.2% | 8.6% | 8.9% | 9.0% | |
| – | – | – | – | – | – | – | – | 49.8% | 43.7% | 40.4% | 37.1% | |
| -324.2% | -192.6% | -204.1% | -188.5% | -275.9% | -42.2% | -56.0% | -44.7% | -8.2% | 4.3% | 5.0% | 7.6% | |
| -1,171.4% | -981.7% | -962.9% | -1,037.5% | -1,092.6% | -834.8% | -833.2% | -774.8% | -690.2% | -649.9% | -658.1% | -668.8% | |
| 11.7% | 13.6% | 13.3% | 17.6% | 14.6% | 12.7% | 27.7% | 27.7% | 25.7% | 24.3% | 23.2% | 23.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.